의약품 폐기물 관리 시장 : 기회, 성장 동력, 산업 동향 분석 및 예측(2024-2032년)

The Global Pharmaceutical Waste Management Market was valued at USD 4.7 billion in 2023 and is projected to grow at a CAGR of 7.6% from 2024 to 2032. This growth is linked to advancements in waste treatment, heightened environmental concerns, more drug recalls and expired medications, and increasing healthcare expenditures.

Booming pharma sector, driven by rising demand for medications due to an aging population, a surge in chronic diseases, and breakthroughs in medical research, is pushing market growth. For example, a recent United Nations (UN) report forecasts that the global population aged 65 and over will triple in the next three decades, reaching 1.6 billion by 2050, which will constitute over 16% of the global populace. This demographic shift is expected to generate larger volumes of pharmaceutical waste, underscoring the need for efficient waste management systems to handle expired, unused, or contaminated drugs.

Continuous innovations in medical waste management, heightened regulatory scrutiny, a shift towards sustainable practices, and an intensified focus on public health and safety are driving the industry's growth. Additionally, with a global emphasis on stringent regulations and compliance standards, pharmaceutical companies and healthcare providers are adopting robust waste management practices. Regulatory bodies emphasize the safe disposal of pharmaceutical waste to mitigate environmental harm and public health risks, increasing demand for certified waste management services and technologies.

Healthcare facilities and pharmaceutical companies are increasingly turning to specialized third-party providers for their waste management needs. This shift is due to the intricate nature of waste regulations and the expertise required in handling hazardous materials, spurring growth in the waste management service industry.

The overall pharmaceutical waste management industry is segmented based on waste type, treatment site, waste generator, and region.

In 2023, the non-hazardous waste segment, encompassing general pharmaceutical waste, packaging waste, and other non-hazardous materials, generated the highest revenue of USD 3.6 billion. The growth is led by an uptick in non-hazardous waste, including unused, expired, and over-the-counter medications necessitating proper disposal. As medication consumption rises, so does the demand for efficient non-hazardous waste management systems. The cost-effectiveness of non-hazardous waste disposal methods facilitates proper waste management practices across healthcare facilities, pharmacies, and households.

In 2023, the offsite treatment segment led the market with a commanding share of 59%. Offsite treatment significantly reduces the risks tied to handling and processing pharmaceutical waste within healthcare settings. By transferring waste to specialized treatment centers, organizations can mitigate risks of contamination, exposure to hazardous substances, and potential accidents. These offsite facilities, equipped with the necessary expertise and infrastructure, can safely manage and treat diverse pharmaceutical waste types. They often utilize advanced technologies and equipment, such as incineration, chemical treatment, and waste-to-energy conversion, which may be unfeasible for smaller healthcare facilities. Their capability to process large waste volumes and offer specialized services further amplifies the demand for offsite treatment.

In 2023, North America pharmaceutical waste management market accounted for a substantial USD 1.7 billion and is projected to grow at a CAGR of 7% from 2024 to 2032. The region is leading the charge in adopting cutting-edge waste management technologies. Innovations like automated waste tracking, advanced incineration methods, and sophisticated chemical treatments are bolstering the efficiency and safety of pharmaceutical waste management. The adoption of these technologies not only enhances market growth but also ensures more effective and compliant solutions. Additionally, the Corporate Social Responsibility (CSR) initiatives, along with investments in sustainable practices is shaping the regional market outlook.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising healthcare expenditures and drug consumption
    • 3.2.1.2 Growth in the pharmaceutical industry
    • 3.2.1.3 Technological advancements in waste management
    • 3.2.1.4 Focus on healthcare facility standards
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs of waste management solutions
    • 3.2.2.2 Challenges in waste segregation
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Methods of treating pharmaceutical waste
• 3.9 Value chain analysis
• 3.10 Gap analysis
• 3.11 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Waste Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hazardous waste
  • 5.2.1 Infectious waste
  • 5.2.2 Chemical waste
  • 5.2.3 Radioactive waste
  • 5.2.4 Other hazardous wastes
• 5.3 Non-hazardous waste
  • 5.3.1 General pharmaceutical waste
  • 5.3.2 Packaging waste
  • 5.3.3 Other non-hazardous wastes

Chapter 6 Market Estimates and Forecast, By Treatment Site, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Offsite treatment
• 6.3 Onsite treatment

Chapter 7 Market Estimates and Forecast, By Waste Generator, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Pharmaceuticals and biotech companies
• 7.4 Pharmacies
• 7.5 Other waste generators

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Biomedical Waste Solutions
• 9.2 BWS Incorporated
• 9.3 Casella Waste Systems, Inc.
• 9.4 Clean Harbors
• 9.5 Cleanaway Waste Management Limited
• 9.6 EcoMed Services
• 9.7 Gamma Waste Services
• 9.8 GRP and Associates, Inc.
• 9.9 Hazardous Waste Experts
• 9.10 MedPro Disposal
• 9.11 REMONDIS SE and Co. KG
• 9.12 Reworld Waste, LLC.
• 9.13 Stericycle, Inc.
• 9.14 VEOLIA ENVIRONNEMENT
• 9.15 Waste Management, Inc.